These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 37470147)
21. Phosphodiesterase-4D Knock-down in the Prefrontal Cortex Alleviates Chronic Unpredictable Stress-Induced Depressive-Like Behaviors and Memory Deficits in Mice. Wang ZZ; Yang WX; Zhang Y; Zhao N; Zhang YZ; Liu YQ; Xu Y; Wilson SP; O'Donnell JM; Zhang HT; Li YF Sci Rep; 2015 Jul; 5():11332. PubMed ID: 26161529 [TBL] [Abstract][Full Text] [Related]
22. Phosphodiesterase 4 inhibitors in diabetic nephropathy. Ookawara M; Nio Y Cell Signal; 2022 Feb; 90():110185. PubMed ID: 34785349 [TBL] [Abstract][Full Text] [Related]
23. Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIF. Pullamsetti SS; Banat GA; Schmall A; Szibor M; Pomagruk D; Hänze J; Kolosionek E; Wilhelm J; Braun T; Grimminger F; Seeger W; Schermuly RT; Savai R Oncogene; 2013 Feb; 32(9):1121-34. PubMed ID: 22525277 [TBL] [Abstract][Full Text] [Related]
24. Phosphodiesterase 4 and its inhibitors in inflammatory diseases. Jin SL; Ding SL; Lin SC Chang Gung Med J; 2012; 35(3):197-210. PubMed ID: 22735051 [TBL] [Abstract][Full Text] [Related]
26. Design and synthesis of 4,5,6,7-tetrahydro-1H-1,2-diazepin-7-one derivatives as a new series of Phosphodiesterase 4 (PDE4) inhibitors. Guariento S; Karawajczyk A; Bull JA; Marchini G; Bielska M; Iwanowa X; Bruno O; Fossa P; Giordanetto F Bioorg Med Chem Lett; 2017 Jan; 27(1):24-29. PubMed ID: 27890378 [TBL] [Abstract][Full Text] [Related]
27. Advances in the development of phosphodiesterase 7 inhibitors. Huang JX; Zhu BL; Xu JP; Zhou ZZ Eur J Med Chem; 2023 Mar; 250():115194. PubMed ID: 36796299 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of type 4 cyclic nucleotide phosphodiesterase blocks intracellular TLR signaling in chronic lymphocytic leukemia and normal hematopoietic cells. Tan Y; Watkins AA; Freeman BB; Meyers JA; Rifkin IR; Lerner A J Immunol; 2015 Jan; 194(1):101-12. PubMed ID: 25416804 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of phosphodiesterase-4 in the spinal dorsal horn ameliorates neuropathic pain via cAMP-cytokine-Cx43 signaling in mice. Zhang FF; Wang H; Zhou YM; Yu HY; Zhang M; Du X; Wang D; Zhang F; Xu Y; Zhang JG; Zhang HT CNS Neurosci Ther; 2022 May; 28(5):749-760. PubMed ID: 35156776 [TBL] [Abstract][Full Text] [Related]
31. Characterization of LY2775240, a selective phosphodiesterase-4 inhibitor, in nonclinical models and in healthy subjects. Patel DR; Urva S; Ho S; Buckman CJ; Ma Y; Lim J; Sissons SE; Zuniga MS; Philips D; Cox K; Dairaghi DJ Clin Transl Sci; 2021 May; 14(3):1037-1048. PubMed ID: 33382916 [TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological evaluation of pyridazinone derivatives as potential anti-inflammatory agents. Barberot C; Moniot A; Allart-Simon I; Malleret L; Yegorova T; Laronze-Cochard M; Bentaher A; Médebielle M; Bouillon JP; Hénon E; Sapi J; Velard F; Gérard S Eur J Med Chem; 2018 Feb; 146():139-146. PubMed ID: 29407945 [TBL] [Abstract][Full Text] [Related]
33. Targeting phosphodiesterase 4 as a potential therapeutic strategy for enhancing neuroplasticity following ischemic stroke. Wang H; Gaur U; Xiao J; Xu B; Xu J; Zheng W Int J Biol Sci; 2018; 14(12):1745-1754. PubMed ID: 30416389 [TBL] [Abstract][Full Text] [Related]
34. Biphenyl Pyridazinone Derivatives as Inhaled PDE4 Inhibitors: Structural Biology and Structure-Activity Relationships. Gràcia J; Buil MA; Castro J; Eichhorn P; Ferrer M; Gavaldà A; Hernández B; Segarra V; Lehner MD; Moreno I; Pagès L; Roberts RS; Serrat J; Sevilla S; Taltavull J; Andrés M; Cabedo J; Vilella D; Calama E; Carcasona C; Miralpeix M J Med Chem; 2016 Dec; 59(23):10479-10497. PubMed ID: 27933955 [TBL] [Abstract][Full Text] [Related]
35. Dysregulation of hepatic cAMP levels via altered Pde4b expression plays a critical role in alcohol-induced steatosis. Avila DV; Barker DF; Zhang J; McClain CJ; Barve S; Gobejishvili L J Pathol; 2016 Sep; 240(1):96-107. PubMed ID: 27287961 [TBL] [Abstract][Full Text] [Related]
36. Spatiotemporal dynamics of beta-adrenergic cAMP signals and L-type Ca2+ channel regulation in adult rat ventricular myocytes: role of phosphodiesterases. Leroy J; Abi-Gerges A; Nikolaev VO; Richter W; Lechêne P; Mazet JL; Conti M; Fischmeister R; Vandecasteele G Circ Res; 2008 May; 102(9):1091-100. PubMed ID: 18369156 [TBL] [Abstract][Full Text] [Related]
37. Phosphodiesterase 4D: an enzyme to remember. Ricciarelli R; Fedele E Br J Pharmacol; 2015 Oct; 172(20):4785-9. PubMed ID: 26211680 [TBL] [Abstract][Full Text] [Related]
38. Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D. Sierksma AS; van den Hove DL; Pfau F; Philippens M; Bruno O; Fedele E; Ricciarelli R; Steinbusch HW; Vanmierlo T; Prickaerts J Neuropharmacology; 2014 Feb; 77():120-30. PubMed ID: 24067928 [TBL] [Abstract][Full Text] [Related]
39. TAS-203, an oral phosphodiesterase 4 inhibitor, exerts anti-inflammatory activities in a rat airway inflammation model. Demizu S; Asaka N; Kawahara H; Sasaki E Eur J Pharmacol; 2019 Apr; 849():22-29. PubMed ID: 30716315 [TBL] [Abstract][Full Text] [Related]